Developing a Vaccine for CMV
Over 30% of children and 50% of adults are already infected with Cytomegalovirus (CMV), a virus in the herpes family.
This study is examining an investigational vaccine for preventing the spread of CMV in girls and women ages 16 to 40 years old.
- 24-hour access to MBR’s doctors/medical staff.
- World class medical oversight.
- Free of Charge!
Free of Charge!
- Insurance is NOT required to participate.
- Free services include:
– Study related medication
– Doctor’s visits
– Physical exams
receive up to a $1,745 for study-related time & travel
- Those who qualify and choose to participate may receive up to a $1,745 stipend for study-related time & travel.
“A Cytomegalovirus vaccine could be a breakthrough in reducing the prevalence of this virus and protect people from its possible health impacts.“
The first step is to learn more and see if you qualify. After registering, a clinical research coordinator will contact you and answer your questions
Call or text +1 704 283 7359
Visit Our Center
See If You Qualify
Our facility is state of the art.
Visit our center for a prescreening visit to see if you qualify.
343 Venus Street, Monroe, NC 28112
What our Patients say about our services
Square feet Dedicated Research Facility
Recreational Area Comfortable Recliners
Free entertainment options
First Class Service from our Nurses and Staff
High Speed Wifi
mRNA Cytomegalovirus Vaccine Study
You are being invited to take part in this research study to test a study vaccine called mRNA-1647 that is being developed for preventing cytomegalovirus (CMV) infection in people. CMV is a common virus that can spread easily through an infected person’s saliva or other body fluids such as blood, urine and breast milk.
If a pregnant woman has a CMV infection, it may be passed to her unborn child. CMV is the most common congenital viral infection. Although approximately 4 in 5 infants who are born with congenital CMV are well, 1 in 5 infants with congenital CMV infection have or develop lifelong disabilities such as hearing loss, learning problems, or vision abnormalities and rarely, it can cause death.
COVID / Flu Combo
343 Venus Street, Monroe, NC 28112
Office Phone: 704-283-7369
Frequently Asked Questions
What is CMV?
- CMV is a usually harmless herpes virus, but it can cause serious health problems, including blindness, in people with weakened immune systems. If a baby is born with the CMV virus, 1 out of 5 babies could develop a long-term health problem.
What are the symptoms of CMV?
- Most people who are infected with CMV do not have any symptoms. When symptoms occur, they may include fever, fatigue, and a skin rash. In some cases, CMV can cause more severe problems, such as pneumonia, hepatitis, or meningitis.
How can CMV be prevented?
- You can avoid a CMV infection by washing your hands often and avoiding close contact with those infected. This is of course impossible to do when working with young children or while giving birth. That is why most people are infected at birth. At Monroe Biomedical Research, we are investigating a vaccine for preventing the spread of CMV.
How is CMV transmitted?
- CMV is transmitted through direct contact with saliva, blood, urine, or other body fluids from an infected person. It can also spread through contact with objects or surfaces contaminated with the virus, and a pregnant woman could also pass the virus into the newborn body.
What is the treatment for CMV?
- There is no specific treatment for CMV. Treatment is supportive and may include rest, fluids, and antivirus medications to relieve symptoms and reduce the reproduction of the virus.
How much will the study cost?
- There will be zero costs for the study participant to take part in the CMV Study.
What if I am uninsured?
- Proof of insurance is NOT required to participate in this study. All medical oversight over the course of your study participation is included.
What does investigational medication mean?
- An Investigational medication (also known as investigational new drug) has been approved by the Food and Drug Administration (FDA) for testing in people in a clinical study, but has not been approved for general use, distribution or sale. It is through clinical research that these medications receive full approval by the FDA.
How will I be compensated for participating?
- Participants receive a check following each study visit. For this study, those that qualify and choose to participate could receive a total payment of up to $1,745.